NEW YORK, Jan. 12, 2026 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) announced today that its 2026 funding opportunities are officially open for applications.

RC148 is a novel PD-1/VEGF bispecific antibody being evaluated in multiple advanced solid tumors including certain lung cancersNORTH CHICAGO, Ill.

Strategic collaboration expands taletrectinib global reach with a leading oncology partnerEisai will receive exclusive development, registration and commercialization rights for taletrectinib for the ...

Eisai And Nuvation Bio Enter Into Exclusive Licensing Agreement For Taletrectinib In Europe And Additional Countries Outside The U.S., China And Japan. Eisai and Nuvation Bio Enter into Exclusive ...

She explained: "I was actually planting a tree in my backyard and I collapsed in pain and I thought I better get myself off ...

Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced preliminary fourth quarter and full year 2025 net product revenue ...

Ready to protect your peace? Discover 5 types of day trips that define the Soft Life. From therapeutic agritourism to luxury ...

Bob Weir of the Grateful Dead planned to do a musical at the Old Globe Theater, 19 years after he was arrested at the San ...

Since Dr. Rubinstein began his tenure as Interim CMO in September 2025, the company has achieved significant clinical and ...

It's difficult sticking to New Year's resolutions: just 8 per cent of people manage to keep their resolutions going for even ...

Tensions between President Trump and Federal Reserve Chair Jerome Powell have reached a fever pitch after Powell confirmed ...

Harmony Biosciences Holdings, Inc. today announced strong preliminary, unaudited net product revenue for Q4 and full year ...